about
The FGF/FGFR axis as a therapeutic target in breast cancer.Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.Fibroblast growth factor receptors in breast cancer.Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAFFine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.The ins and outs of fibroblast growth factor receptor signalling.Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer.Regulation of FGF10 Signaling in Development and DiseaseNeomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
P2860
Q34495216-2BC1B4D2-76A0-40FD-8E0B-00A7713674E8Q34525925-3FBA5232-0BD3-4049-863E-3D1E880E2B76Q34556066-A9E4DA57-188C-4634-A7EE-A65C10D451B5Q35781357-CD2C4825-62CB-41ED-8E99-6F6D9F0792DEQ36983860-F5109EA0-648E-4781-81E8-F4592F6E8F67Q37149773-48A4C5B0-4BA5-4175-A70B-9CA0C7366761Q37367871-371CAE2F-3042-45FE-BAA9-990E5BF177CDQ38208062-F5F17A40-79DF-4585-82AD-02CD2CC4B9A8Q44643445-6FD4CFEB-F306-493B-98C9-2E288A2A17A4Q58572262-29295C05-8F36-499E-8E30-6AE8F5DE43C5Q58617548-3CC22D64-9463-4228-9EED-CB34947E23DC
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Activating somatic FGFR2 mutations in breast cancer
@ast
Activating somatic FGFR2 mutations in breast cancer
@en
Activating somatic FGFR2 mutations in breast cancer
@nl
type
label
Activating somatic FGFR2 mutations in breast cancer
@ast
Activating somatic FGFR2 mutations in breast cancer
@en
Activating somatic FGFR2 mutations in breast cancer
@nl
prefLabel
Activating somatic FGFR2 mutations in breast cancer
@ast
Activating somatic FGFR2 mutations in breast cancer
@en
Activating somatic FGFR2 mutations in breast cancer
@nl
P2093
P2860
P1433
P1476
Activating somatic FGFR2 mutations in breast cancer
@en
P2093
Alexandra Becker
Bernd Wollnik
Edyta Rohmann
Nadine Reintjes
P2860
P304
P356
10.1371/JOURNAL.PONE.0060264
P407
P577
2013-03-20T00:00:00Z